Immunotherapy

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

Immunotherapy topic overview

The analysis highlights Suppression immunotherapies, Helminthic therapies and Activation immunotherapies as prominent areas in the source structure around Immunotherapy.

Related topics: 124
Source areas: 5
Connected nodes: 129
Extracted relationships: 43
Concept neighborhoods: 52
Bridge connections: 129

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Overview · 67 topics

Suppression immunotherapies · 19 topics

Helminthic therapies · 18 topics

Activation immunotherapies · 16 topics

Immune enhancement therapy · 4 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

MeSH: D007167
OPS-301 code: 8-03

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Immune system
Autoimmune disorders Autoimmune disorder
Infectious diseases Infectious disease
Allergies
Vaccines Vaccine
Immune modulators Immune modulator
Monoclonal antibodies
Lymphocytes Lymphocyte
Macrophages Macrophage
Dendritic cells Dendritic cell
Natural killer cells Natural killer cell
CD8+ T cells Cytotoxic T cell
Granulocyte colony-stimulating factor
Interferons Interferon
Imiquimod
Bacteria
IL-2 Interleukin-2
IL-7 Interleukin-7
IL-12 Interleukin 12
Chemokines Chemokine
Glucans Glucan
Dendritic cells (DC) Dendritic cells
Cytotoxic
Antigen
Antigen-presenting cell
Transfected Transfection
Viral vector
B cells B cell
Cancer vaccine
Sipuleucel-T
DC-based vaccination Dendritic cells- based cancer vaccines
Monocytes Monocyte
CD34
TLR Toll-like receptor
Cytokine
Flt3L FMS-like tyrosine kinase 3 ligand
GM-CSF Granulocyte-macrophage colony-stimulating factor
CD40 CD40 (protein)
C-type lectin receptors C-type lectin receptor
Chemokine receptors Chemokine receptor
Induced pluripotent stem cells Induced pluripotent stem cell
Neoantigen
Adoptive cell transfer
In vitro
Genetically engineered T cells Genetically engineered T cell
Retrovirus
T cell receptor
Genome
Skin cancer
Myeloablative Hematopoietic stem cell transplantation
Anti-PD-1/PD-L1 PD-1 and PD-L1 inhibitors
CTLA-4
PD-1 Programmed cell death protein 1
T cell activation
Apoptosis
Melanoma
Breast cancer
Bladder cancer
Cervical cancer
Colon cancer Colorectal cancer
Head and neck cancer
Hodgkin lymphoma
Cancer immunotherapy
Immunogenic Immunogenicity
LAG-3 Lymphocyte-activation gene 3
TIM3 HAVCR2
TIGIT

Activation immunotherapies

Nobel Prize
James P. Allison
Tasuku Honjo
BCG vaccine
Tuberculosis
Monoclonal antibodies Monoclonal antibody
Rituximab
Lymphocytes
Cytokines
T cells
Warts Wart
Actinic keratoses
Basal cell cancer
Vaginal intraepithelial neoplasia
Trichophytin Trichophytin?action=edit&redlink=1
Lung Lung cancer

Immune enhancement therapy

Suppression immunotherapies

Immune suppression
Immune response
Autoimmune diseases
Rejection Transplant rejection
Organ transplantation Organ transplant
CD4+ T-cells T cell
Autoimmune response
Tolerogenic therapy
Immune tolerance
Autoimmune disease
Regulatory immune cells Regulatory T cell
Rheumatoid arthritis
Type 1 diabetes
Allergies Allergy
Antihistamines Antihistamine
Corticosteroids
Allergens Allergen
Anaphylaxis
Oral immunotherapy

Helminthic therapies

Ova Ovum
Trichuris suis
Necator americanus
Helminthic therapy
Multiple sclerosis
Crohn's disease
Th1 / Th2 T helper cell
Interferon-gamma
Tumor necrosis factor-alpha Tumour Necrosis Factor
IL-10 Interleukin 10
IL-4 Interleukin-4
IL-5 Interleukin 5
IL-13 Interleukin 13
Interleukin
Crohn's
Ulcerative colitis
Celiac disease Coeliac disease
Symbiotic Symbionts

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Immunotherapy connects Entity context

The extracted context around Immunotherapy shows recurring relationship patterns in the source. For example, Immunotherapy → Allison, BCG, Cancer, In, James, Medicine, Nobel Prize, One, Physiology, Randomized, Tasuku Honjo, The Another extracted example is Immunotherapy → Allergen, Subcutaneous, This, While. Use these groups to spot repeated connection types before inspecting the individual relationships.

Top relations

related to Cancer · 12

Immunotherapy → Allison, BCG, Cancer, In, James, Medicine, Nobel Prize, One, Physiology, Randomized, Tasuku Honjo, The

related to Allergen immunotherapy · 4

Immunotherapy → Allergen, Subcutaneous, This, While

related to Immunomodulators · 2

Immunotherapy → Immunomodulators, They

MeSH · 1

Immunotherapy → D007167

OPS-301 code · 1

Immunotherapy → 8-03

is a · 1

Immunotherapy → use of BCG vaccine

see also · 1

Immunotherapy → Biological

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

cells immune cell cancer therapy antigen response system antibodies autoimmune patients responses specific melanoma allergies use disease therapies immunosuppressive also

Immunotherapy relationships Subject–Predicate–Object triples

TTTA extracted 43 structured relationships around Immunotherapy. Examples in this analysis include Immunotherapy → MeSH → D007167 and Immunotherapy → OPS-301 code → 8-03. The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
Immunotherapy	MeSH	D007167	1.00	infobox
Immunotherapy	OPS-301 code	8-03	1.00	infobox
Immunotherapy	is a	use of BCG vaccine	0.90	text
autoimmune disorders	instance of	including strategies to stimulate or suppress immune activity against other diseases	0.80	text
infectious diseases	instance of	including strategies to stimulate or suppress immune activity against other diseases	0.80	text
and allergies	instance of	including strategies to stimulate or suppress immune activity against other diseases	0.80	text
lymphocytes	instance of	Immune effector cells	0.80	text
macrophages	instance of	Immune effector cells	0.80	text
dendritic cells	instance of	Immune effector cells	0.80	text
natural killer cells	instance of	Immune effector cells	0.80	text
and cytotoxic T lymphocytes work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells	instance of	Immune effector cells	0.80	text
granulocyte colony-stimulating factor	instance of	Vaccine-induced immunity to COVID-19 relies mostly on an immunomodulatory T-cell response.Therapies	0.80	text

Related concept clusters Concept neighborhoods

The concept neighborhoods around Immunotherapy bring nearby vocabulary together. In this analysis, examples include Cancer, Allergen and Immune. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

Immunotherapy
- Cancer
- Allergen
- Immune
- Allergies
- Specific
- Cell
- Checkpoint
- First
- Therapies
- Treatment
- Disease
- Responses
immunotherapy
- Cancer
- Allergen
- Immune
- Allergies
- Specific
- Cell
- Checkpoint
- First
- Therapies
- Treatment
- Disease
- Responses
immune system
- System
- Cells
- Body
- Immunosuppressive
- Response
- Cancer
- Immunotherapy
- Autoimmune
- Responses
- Used
- Inhibitors
- Antibodies
immune modulators
- System
- Cells
- Response
- Cancer
- Immunotherapy
- Responses
- Autoimmune
- Body
- Inhibitors
- Immunosuppressive
- Antibodies
- Therapy
monoclonal antibodies
- Inhibitors
- Use
- Specific
- Checkpoint
- Receptors
- Treatment
- Cell
- Responses
- Immune
- Antigen
- Response
- Cancer
dendritic cells
- Immune
- Cytotoxic
- Antigen
- Cell
- T-cells
- Lymphocytes
- Adoptive
- Response
- Dendritic
- Therapy
- Immunosuppressive
- Body
natural killer cells
- Immune
- Antigen
- Cell
- Cytotoxic
- Lymphocytes
- Adoptive
- Response
- Dendritic
- Therapy
- Immunosuppressive
- Immunotherapy
- Therapies
cd8+ t cells
- Immune
- Antigen
- Cell
- Cytotoxic
- Lymphocytes
- Adoptive
- Response
- Dendritic
- Therapy
- Immunosuppressive
- Immunotherapy
- Therapies

Connections between topic areas Semantic bridges

For Immunotherapy, one of the stronger structural bridges in this analysis connects Immunotherapy with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

Immunotherapy — Overview · splits 62 ⟂ 68

Immunotherapy — Suppression immunotherapies · splits 110 ⟂ 20

Immunotherapy — Helminthic therapies · splits 111 ⟂ 19

Immunotherapy — Activation immunotherapies · splits 113 ⟂ 17

Immunotherapy — Immune enhancement therapy · splits 125 ⟂ 5

Map overview Semantic statistics

Immunotherapy

Nodes130

Edges129

Triples43

Avg. degree1.98

Density0.015385

Components1

Source & methodology

TTTA analyzes the structure around Immunotherapy to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Suppression immunotherapies, Helminthic therapies & Activation immunotherapies, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Immunotherapy · EN edition · Analysis: TopicsToTalkAbout